Press release
Global Melanoma Cancer Diagnostics Market Analysis Covers Cost Structure, Demand Rate, Growth, Trends, and Forecast till 2022 || Key Participants- Foundation Medicine Inc., Cancer Genetics Inc., Pathway Genomics Corporation, Abbott Laboratories, Myriad Ge
Inquiry to get a Free Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=57
Melanoma or malignant melanoma is a common type of skin cancer where melanocytes, cells containing pigments, begin to grow rapidly. Since occurrence of melanoma is restricted to skin, mouth, intestines or eyes, the diagnostics of melanoma comprises of multiple tests & screening methods such as excisional biopsy, lymph node status analysis, shave biopsy, and fine needle aspirate test.
The global melanoma cancer diagnostics market is projected to grow at a steady CAGR during the forecast period 2017-2027.
The melanoma cancer diagnostics market will be influenced by a combination of macroeconomic and microeconomic factors. Increasing spending on healthcare and advances in cancer detection and management are expected to contribute to the growth of the melanoma cancer diagnostics market. However, dearth of advanced solutions in developing countries will continue to pose growth challenges.
Analysis by Test Type
By test type, the BRAF mutation test type segment will continue to be used widely for detecting the early onset of melanoma. In terms of revenue share, North America will account for majority share of revenues for the BRAF mutation segment globally. Use of BRAF mutation test type will also remain prevalent in Europe and APEJ.
The CTC segment will grow at a higher CAGR than BRAF mutation test type, with North America holding largest market share. However, it is the APEJ market where revenues will grow at the highest pace.
The immunohistochemistry segment of the global melanoma market is valued at over US$ 80 million in 2017. North America will remain the largest market for immunohistochemistry, followed by Europe and APEJ. Overall, the immunohistochemistry segment is projected to grow at a significant CAGR through 2022.
Analysis by End-Users
By end-users, the key segments of melanoma cancer diagnostics market include hospital associated labs, independent diagnostic laboratories, cancer research institutes, and ‘others’.
The hospital associated labs segment in North America is currently valued at over US$ 137 million, and is expected to grow at a steady CAGR through 2022. The hospital associated labs segment in Europe is anticipated to grow at a significant CAGR through 2022.
Independent diagnostic laboratories end-user segment in North America is expected to surpass US$ 100 million in revenues by 2022, growing at a high single-digit CAGR.
Browse here to get complete information about Melanoma Cancer Diagnostics Market: https://www.factmr.com/report/57/melanoma-cancer-diagnostics-market
Region-wise Analysis
North America will remain an attractive market for global melanoma cancer diagnostic market. As discussed previously, BRAF mutation will remain the most widely used test type, followed by CTC. Hospital associated labs will continue to be the largest end-users in the North America melanoma cancer diagnostics market.
Europe, the second-largest market for melanoma cancer diagnostics, will continue to offer growth opportunities to manufacturers. By test type, the CTC cancer diagnostics market will continue to grow at highest CAGR, whereas hospital associated labs will be the largest end-users.
Overall, North America and Europe will continue to be the two most lucrative markets for melanoma cancer diagnostics globally.
Competition Tracking
The key companies profiled in the Fact.MR’s report on global melanoma cancer diagnostics market include Foundation Medicine, Inc., Cancer Genetics, Inc., Pathway Genomics Corporation, Abbott Laboratories, and Myriad Genetics Inc.
Ask anything with experts about this report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=57
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Melanoma Cancer Diagnostics Market Analysis Covers Cost Structure, Demand Rate, Growth, Trends, and Forecast till 2022 || Key Participants- Foundation Medicine Inc., Cancer Genetics Inc., Pathway Genomics Corporation, Abbott Laboratories, Myriad Ge here
News-ID: 1249119 • Views: …
More Releases from Fact.MR
Organic Mattress Market Forecasted to Achieve US$ 13.87 Billion by 2032
The global Organic Mattress Market (유기농 매트리스 시장) was valued at US$ 6.31 Billion in 2022. Predicted to grow at a significant CAGR of 8.2% from 2022 to 2032, it is expected to reach US$ 13.87 Billion by 2033. The organic mattress market has witnessed a surge in popularity in recent years as consumers become increasingly conscious of the materials they bring into their homes. Unlike conventional mattresses made with…
Wireless Network Test Equipment Market to Reach $9.1 Billion by 2032 with 7.6% C …
The global Wireless Network Test Equipment Market (무선 네트워크 테스트 장비 시장) was valued at US$ 4.36 Billion in 2022. Predicted to grow at a significant CAGR of 7.6% from 2022 to 2032, it is expected to reach US$ 9.1 Billion by 2032. The wireless network test equipment market plays a crucial role in ensuring the reliability, performance, and efficiency of wireless communication networks. These testing tools are essential for…
Smartwatches Market to Expand at 17.8% CAGR, Reaching $121.5 Billion by 2032
The global smartwatches market (Αγορά έξυπνων ρολογιών) was valued at US$ 23.5 billion in 2022 and is forecasted to achieve a significant milestone, reaching US$ 121.5 billion by 2032. According to the latest findings from Fact.MR, this revised study anticipates remarkable growth, with smartwatch sales projected to soar at an impressive Compound Annual Growth Rate (CAGR) of 17.8% through the year 2032.
Smartwatches have emerged as one of the most sought-after…
Maple Water Market Surges at 10.2% CAGR, Reaching $706.95 Million by 2033
The global maple water market (Margadh Uisce Maple) reached a value of US$ 242.88 million in 2022, experiencing steady growth with a Compound Annual Growth Rate (CAGR) of 7.9% from 2018 to 2022. Forecasts indicate a robust expansion ahead, with the market projected to surge at a CAGR of 10.2%, aiming to achieve a valuation of US$ 706.95 million by the conclusion of 2033.
Maple water, also known as sap, is…
More Releases for Melanoma
Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
Europe and Israel Mobile Applications for Melanoma Detection Market: Rising prev …
According to the TMR report, the Europe mobile applications for melanoma detection market could collect a larger revenue of around US$1.5 mn by the end of 2022. Even though Greece is dealing with economic volatility, it has been prognosticated to exhibit a perpetually elevating growth until the same year.
Rise in Mortality Rate and Melanoma Incidence Puts Heavy Influence on Early Diagnosis
Europe and Israel mobile applications for melanoma detection market has…
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
